Monitoring of asthma control in children

Chitra Dinakar1

  • 1Section of Allergy/Asthma/Immunology, Children's Mercy Hospital, University of Missouri in Kansas City, Kansas City, Missouri 64108, USA. cdinakar@cmh.edu

Insights

Monitoring asthma control in children is evolving. New methods like questionnaires, biomarkers, and electronic lung function tests offer better insights for personalized asthma management.

Area of Science:

  • Pediatric Pulmonology
  • Asthma Management
  • Biomarkers in Respiratory Disease

Background:

  • Asthma management has shifted from assessing severity to focusing on control.
  • Optimal asthma control requires titrating treatment based on control levels assessed at clinic visits.

Purpose of the Study:

  • To review recent advances in monitoring asthma control in children.
  • To explore new methods beyond traditional symptom and pulmonary function assessments.

Main Methods:

  • Review of recent advances in asthma control monitoring for children.
  • Inclusion of questionnaires (e.g., Childhood Asthma Control Test).
  • Analysis of biomarkers (e.g., fractional exhaled nitric oxide).
  • Evaluation of electronic lung function monitoring (peak flow, FEV).
  • Consideration of lung growth, bronchial hyper-responsiveness, and adherence measures.

Main Results:

  • Advances include the Childhood Asthma Control Test, fractional exhaled nitric oxide, and electronic lung function monitoring.
  • Other indicators include lung growth, bronchial hyper-responsiveness, and adherence.
  • Proof-of-concept studies in adults show promise for non-traditional markers.

Conclusions:

  • Newer methods for monitoring asthma control in children are emerging.
  • Further research is needed to apply adult findings (airway hyper-responsiveness, sputum eosinophilia, FeNO) to pediatric populations.
  • These advancements aim to fine-tune asthma control and inhaled corticosteroid use.
Abstract

Related Concept Videos

Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma-IV: Nursing Management01:30

Asthma-IV: Nursing Management

The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma